Fluoxymesterone
Other name：halotestina
CAS register number：76-43-7
EINECS：200-961-8
Fórmula molecular：C20H29FO3
Peso molecular：336.44
Punto de fusión：240 ºC
Ensayo：97.0~103.0%
Uso：Treating a deficiency of the male hormone testosterone when the body does not make enough. used to stimulate puberty in males with delayed puberty. Treating advanced breast cancer in women who are 1 a 5 years past menopause.
La fluoximesterona es un derivado sintético de la testosterona., pero en particular es un derivado de la metiltestosterona. (Testosterona que ha sido metilada).
Generalmente se considera un esteroide anabólico oral muy fuerte que no puede aromatizarse en estrógeno y también exhibe una fuerza androgénica muy fuerte..
Effects
maintenance and gaining of lean mass and tissue repair following various conditions of trauma (quemaduras, bone fractures, malnutrition, muscle-wasting diseases, treatment of paraplegics, and as an adjunct to chronic administration of corticosteroids).
Males its use was indicated for the treatment of insufficient androgen production (hypogonadism or andropause).
In females, Halo would be approved for use in treating chronic dysfunctional uterine bleeding as well as female breast cancer.
Halotestin will exert performance enhancing benefits without the unwanted increases in weight that may slow down an athlete, such as a sprinter, who requires the least weight as possible in order to maximize speed efficiency while still receiving that benefit of performance enhancement.
